Cannabinoids in trigeminal neuralgia
Trigeminal neuralgia is the most common craniofacial pain syndrome. This disorder causes severe facial pain and is described as very acute, similar to an electric shock to the jaw, eye region, teeth or gums. The authors present a clinical case involving a 46-year-old patient with trigeminal neuralgi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Jezik: | English |
| Izdano: |
Publiediting
2021-09-01
|
| Serija: | Pathos |
| Teme: | |
| Online dostop: | https://www.pathos-journal.com/2021_2_218.html |
| _version_ | 1828146682321174528 |
|---|---|
| author | Antonino Genovese Antonella Calabrò Davide Capone |
| author_facet | Antonino Genovese Antonella Calabrò Davide Capone |
| author_sort | Antonino Genovese |
| collection | DOAJ |
| description | Trigeminal neuralgia is the most common craniofacial pain syndrome. This disorder causes severe facial pain and is described as very acute, similar to an electric shock to the jaw, eye region, teeth or gums. The authors present a clinical case involving a 46-year-old patient with trigeminal neuralgia; in this study, cannabinoid treatment (19% THC; <1% CBD) showed good pain relief. |
| first_indexed | 2024-04-11T20:51:24Z |
| format | Article |
| id | doaj.art-cab901b8cdfd421fb0920a16a27798ce |
| institution | Directory Open Access Journal |
| issn | 1593-2354 2385-0744 |
| language | English |
| last_indexed | 2024-04-11T20:51:24Z |
| publishDate | 2021-09-01 |
| publisher | Publiediting |
| record_format | Article |
| series | Pathos |
| spelling | doaj.art-cab901b8cdfd421fb0920a16a27798ce2022-12-22T04:03:51ZengPublieditingPathos1593-23542385-07442021-09-01282Cannabinoids in trigeminal neuralgiaAntonino Genovese0Antonella Calabrò1Davide Capone2Anaesthesia, UOS Spoke Pain Therapy Unit, ASP Messina, Patti, ItalyUOC Occupational Medicine, University of Messina, ItalyAnaesthesia, Intensive Care and Pain Therapy Unit, University of Palermo, ItalyTrigeminal neuralgia is the most common craniofacial pain syndrome. This disorder causes severe facial pain and is described as very acute, similar to an electric shock to the jaw, eye region, teeth or gums. The authors present a clinical case involving a 46-year-old patient with trigeminal neuralgia; in this study, cannabinoid treatment (19% THC; <1% CBD) showed good pain relief.https://www.pathos-journal.com/2021_2_218.htmltrigeminal neuralgiacannabinoidsmedical cannabischronic painanalgesia |
| spellingShingle | Antonino Genovese Antonella Calabrò Davide Capone Cannabinoids in trigeminal neuralgia Pathos trigeminal neuralgia cannabinoids medical cannabis chronic pain analgesia |
| title | Cannabinoids in trigeminal neuralgia |
| title_full | Cannabinoids in trigeminal neuralgia |
| title_fullStr | Cannabinoids in trigeminal neuralgia |
| title_full_unstemmed | Cannabinoids in trigeminal neuralgia |
| title_short | Cannabinoids in trigeminal neuralgia |
| title_sort | cannabinoids in trigeminal neuralgia |
| topic | trigeminal neuralgia cannabinoids medical cannabis chronic pain analgesia |
| url | https://www.pathos-journal.com/2021_2_218.html |
| work_keys_str_mv | AT antoninogenovese cannabinoidsintrigeminalneuralgia AT antonellacalabro cannabinoidsintrigeminalneuralgia AT davidecapone cannabinoidsintrigeminalneuralgia |